Relative and absolute quantification enabled us to distinguish different expression levels of the ERBB2 gene in re-amplified WTA products of single breast cancer cells with a comparable level of confidence as in the original WTA samples (Fig 4E, S2 Fig). This evidence concerns the gene ERBB2 and breast carcinoma.